A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes
Clinical trial NCT03526185 · TERMINATED
Trial details
- NCT number
- NCT03526185
- Sponsor
- Yale University
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2020-12-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.